carmot glp-1 RAs gain popularity as cure for obesity, get explored for NASH, CVDs GLP-1 boom causing pharma FOMO

That's why there's a lot of excitement around two new pill forms of the drug

Remember every persons body responds differently

Conversely, DKD in type 2 diabetes mellitus shows greater pathological heterogeneity, with some people developing classical glomerular lesions, while others present with atypical features such as prominent tubulointerstitial damage, vascular abnormalities, or coexisting non-DKD pathology [21,22]

Medications are HSA/FSA eligible, and no insurance membership fee applies

GLP-1 weight-loss drugs pose hidden risks for young women Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers